Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026)
Inogen (INGN) reported Non-Current Deferred Tax Liability of $6.6 million for Q1 2026, down 11.3% year-over-year from $7.4 million in Q1 2025, and down 2.62% quarter-over-quarter from $6.7 million in Q4 2025.
Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Inogen (INGN) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $6.6 million in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $6.6 million, down 11.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.6 million (down 11.3% YoY), and the FY2025 annual result was $6.7 million, down 2.86% from the prior year.
- Non-Current Deferred Tax Liability fell to $6.6 million in Q1 2026 per INGN's latest filing, from $6.7 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $14.0 million in Q4 2022 and troughed at $6.6 million in Q1 2026.
- A 5-year average of $8.3 million and a median of $8.0 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability slumped 38.79% in 2023, then dropped 0.44% in 2024.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $14.0 million in 2022, then sank by 38.79% to $8.5 million in 2023, then decreased by 18.63% to $6.9 million in 2024, then dropped by 2.86% to $6.7 million in 2025, then dropped by 2.62% to $6.6 million in 2026.
- Business Quant data shows INGN's Non-Current Deferred Tax Liability at $6.6 million in Q1 2026, $6.7 million in Q4 2025, and $7.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.57 Mn |
| Mar 31, 2026 | 6.57 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Dec 31, 2023 | 8.54 Mn |